Biotech entity
pharma is the sole category represented across all 1 tracked stories. University of North Carolina is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention University of North Carolina, all published on March 10, 2026.
Last mentioned: Mar 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. University of North Carolina is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention University of North Carolina, all published on March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 19 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University of North Carolina. Shared-story counts are live from our verified record — not editorial picks.
GLP-1 receptor agonists, already dominant in diabetes and obesity, are being investigated for their potential to treat substance use disorders. Early clinical observations and pilot studies suggest these drugs may dampen the brain's reward system, offering a new mechanism for tackling addiction.
University of North Carolina is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
